ABION Inc. (KOSDAQ:203400)
South Korea · Delayed Price · Currency is KRW 3,655.00
+5.00 (0.14%)
At close: Jan 28, 2026
ABION Market Cap
ABION has a market cap or net worth of 337.88 billion as of January 29, 2026. Its market cap has increased by 70.68% in one year.
Market Cap
337.88B
Enterprise Value
357.47B
Revenue
1.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,655.00
Market Cap Chart
Since April 5, 2017, ABION's market cap has increased from 54.88B to 337.88B, an increase of 515.64%. That is a compound annual growth rate of 22.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 337.88B | 19.81% |
| Dec 30, 2025 | 282.02B | 40.69% |
| Dec 30, 2024 | 200.46B | 22.52% |
| Dec 28, 2023 | 163.61B | 29.00% |
| Dec 29, 2022 | 126.83B | -53.68% |
| Dec 30, 2021 | 273.81B | 220.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ToolGen | 525.79B |
| S.Biomedics | 431.00B |
| NIBEC | 403.46B |
| GC Cell | 392.96B |
| Y-Biologics | 389.32B |
| HansBiomed | 378.17B |
| Genome & Company | 321.19B |
| ISU Abxis | 244.95B |